Evaluation of penicillins, cephalosporins, and macrolides for therapy of streptococcal pharyngitis

Stanford T Shulman*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

19 Scopus citations


Objective. To review recent clinical experience with treatment of acute streptococcal pharyngitis with penicillins, cephalosporins, and macrolide antibiotics. Methods. Literature review and analysis. Results and Conclusions. Oral penicillin V administered two to three times daily for 10 days is the treatment of choice for acute streptococcal pharyngitis and is the oral standard against which other treatments should be measured. A single intramuscular dose of benzathine penicillin also remains highly effective. Recent studies evaluating alternative oral agents given for less than 10 days or in once-daily regimens have yielded promising results. Studies should make efforts to exclude chronic streptococcal carriers with intercurrent viral pharyngitis because their inclusion in treatment trials substantially confounds the data. As issues of health care costs assume increasing importance, the cost of newer antimicrobial agents will deter their usage for acute streptococcal pharyngitis.

Original languageEnglish (US)
Pages (from-to)955-959
Number of pages5
Issue number6 II SUPPL.
StatePublished - Jun 19 1996

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health


Dive into the research topics of 'Evaluation of penicillins, cephalosporins, and macrolides for therapy of streptococcal pharyngitis'. Together they form a unique fingerprint.

Cite this